Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1969 Mar;4(3):323–332.

Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen–antibody interaction

G Myllylä, A Vaheri, T Vesikari, K Penttinen
PMCID: PMC1578980  PMID: 5814719

Abstract

A new method of measuring antibodies by observing sedimentation patterns of platelets has been compared with the complement fixation and haemagglutination inhibition techniques in ten cases of Rubella and seven cases of post-Rubella thrombocytopenic purpura. The method is based on the aggregation of platelets by the joint action of antibody and small size antigens. The platelet aggregation method gave exceptionally high titres in cases of post-Rubella thrombocytopenic purpura. Other serologic methods did not give these high titres. The hypothesis that small size virus antigen and antibody against it are both needed to induce thrombocytopenia during the recovery period is discussed. Large amounts of both may result in clinical symptoms.

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACKROYD J. F. Three cases of thrombocytopenic purpura occurring after rubella; with a review of purpura associated with infections. Q J Med. 1949 Oct;18(72):299-318, pl. [PubMed] [Google Scholar]
  2. ADKINS A. T., FERNBACH D. J. THROMBOCYTOPENIC PURPURA FOLLOWING RUBELLA. JAMA. 1965 Jul 19;193:243–245. doi: 10.1001/jama.1965.03090030065027. [DOI] [PubMed] [Google Scholar]
  3. Banatvala J. E., Horstmann D. M., Payne M. C., Gluck L. Rubella syndrome and thrombocytopenic purpura in newborn infants. Clinical and virologic observations. N Engl J Med. 1965 Aug 26;273(9):474–478. doi: 10.1056/NEJM196508262730904. [DOI] [PubMed] [Google Scholar]
  4. Bayer W. L., Sherman F. E., Michaels R. H., Szeto I. L., Lewis J. H. Purpura in congenital and acquired rubella. N Engl J Med. 1965 Dec 16;273(25):1362–1366. doi: 10.1056/NEJM196512162732504. [DOI] [PubMed] [Google Scholar]
  5. Furukawa T., Vaheri A., Plotkin S. A. Growth of rubella virus in BHK21 cells. 3. Production of complement-fixing antigens. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1098–1102. doi: 10.3181/00379727-125-32285. [DOI] [PubMed] [Google Scholar]
  6. GREEN R. H., BALSAMO M. R., GILES J. P., KRUGMAN S., MIRICK G. S. STUDIES ON THE EXPERIMENTAL TRANSMISSION, CLINICAL COURSE, EPIDEMIOLOGY AND PREVENTION OF RUBELLA. Trans Assoc Am Physicians. 1964;77:118–125. [PubMed] [Google Scholar]
  7. HIRSCH E. O., GARDNER F. H. The transfusion of human blood platelets with a note on the transfusion of granulocytes. J Lab Clin Med. 1952 Apr;39(4):556–569. [PubMed] [Google Scholar]
  8. Halonen P. D., Casey H. L., Stewart J. A., Hall A. D. Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med. 1967 May;125(1):167–172. doi: 10.3181/00379727-125-32039. [DOI] [PubMed] [Google Scholar]
  9. LOKIETZ H., REYNOLDS F. A. POSTRUBELLA THROMBOCYTOPENIC PURPURA. J Lancet. 1965 Jan;85:226–230. [PubMed] [Google Scholar]
  10. Lennette E. H., Schmidt N. J., Magoffin R. L. The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status. J Immunol. 1967 Oct;99(4):785–793. [PubMed] [Google Scholar]
  11. Lusher J. M., Zuelzer W. W. Idiopathic thrombocytopenic purpura in childhood. J Pediatr. 1966 Jun;68(6):971–979. doi: 10.1016/s0022-3476(66)80218-4. [DOI] [PubMed] [Google Scholar]
  12. McKay D. G., Margaretten W. Disseminated intravascular coagulation in virus diseases. Arch Intern Med. 1967 Aug;120(2):129–152. [PubMed] [Google Scholar]
  13. Morse E. E., Zinkham W. H., Jackson D. P. Thrombocytopenic purpura following rubella infection in children and adults. Arch Intern Med. 1966 Apr;117(4):573–579. [PubMed] [Google Scholar]
  14. NELSON E. R., BIERMAN H. R. DENGUE FEVER: A THROMBOCYTOPENIC DISEASE? JAMA. 1964 Oct 12;190:99–103. doi: 10.1001/jama.1964.03070150009002. [DOI] [PubMed] [Google Scholar]
  15. Penttinen K., Myllylä G. Interaction in human blood platelets, viruses and antibodies. I. Platelet aggregation test with microequipment. Ann Med Exp Biol Fenn. 1968;46(2):188–192. [PubMed] [Google Scholar]
  16. Rabinovitch M. Phagocytosis: the engulfment stage. Semin Hematol. 1968 Apr;5(2):134–155. [PubMed] [Google Scholar]
  17. SEVER J. L., HUEBNER R. J., CASTELLANO G. A., SARMA P. S., FABIYI A., SCHIFF G. M., CUSUMANO C. L. RUBELLA COMPLEMENT FIXATION TEST. Science. 1965 Apr 16;148(3668):385–387. doi: 10.1126/science.148.3668.385. [DOI] [PubMed] [Google Scholar]
  18. Schmidt N. J., Lennette E. H., Gee P. S. Demonstration of rubella complement-fixing antigens of two distinct particle sizes by gel filtration on sephadex G-200. Proc Soc Exp Biol Med. 1966 Dec;123(3):758–762. doi: 10.3181/00379727-123-31596. [DOI] [PubMed] [Google Scholar]
  19. Staub H. P. Postrubella thrombocytopenic purpura. A report of eight cases with discussion of hemorrhagic manifestations of rubella. Clin Pediatr (Phila) 1968 Jun;7(6):350–356. doi: 10.1177/000992286800700611. [DOI] [PubMed] [Google Scholar]
  20. Vesikari T., Vaheri A. Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J. 1968 Jan 27;1(5586):221–223. doi: 10.1136/bmj.1.5586.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. WALLACE S. J. Thrombocytopenic purpura after rubella. Lancet. 1963 Jan 19;1(7273):139–141. doi: 10.1016/s0140-6736(63)91023-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES